Neuroprotective mechanisms of microglia in ischemic stroke: a review focused on mitochondria
- PMID: 40167874
- DOI: 10.1007/s11033-025-10469-4
Neuroprotective mechanisms of microglia in ischemic stroke: a review focused on mitochondria
Abstract
Stroke encompasses a range of cerebrovascular disorders characterized by high morbidity, disability, and mortality, with ischemic stroke being the predominant type. This condition imposes significant socio-economic and healthcare burdens, and therapeutic options are currently limited. Microglia, the brain's resident immune cells, are rapidly activated following stroke-induced injury and play a pivotal role in the pathogenesis of neuroinflammation and ischemic tissues. Mitochondria participates in and influences the pathological processes of ischemic stroke, including oxidative stress, modulation of microglia phenotype, and axonal regenerative function, and is an essential and often overlooked target in the clinical management of stroke. This paper reviews recent advancements in research on microglia in ischemic stroke, specifically focusing on the contribution of the mitochondria, providing a reference for selecting therapeutic targets and guiding future research directions.
Keywords: Axonal; Ischemic stroke; Microglia; Mitochondria; Oxidative stress.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethical approval: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Glycolytic reprogramming in microglia: A potential therapeutic target for ischemic stroke.Cell Signal. 2024 Dec;124:111466. doi: 10.1016/j.cellsig.2024.111466. Epub 2024 Oct 15. Cell Signal. 2024. PMID: 39419195 Review.
-
RBM3 Promotes Anti-inflammatory Responses in Microglia and Serves as a Neuroprotective Target of Ischemic Stroke.Mol Neurobiol. 2024 Oct;61(10):7384-7402. doi: 10.1007/s12035-024-04052-4. Epub 2024 Feb 22. Mol Neurobiol. 2024. PMID: 38386136
-
Activation of Inflammasomes and Relevant Modulators for the Treatment of Microglia-mediated Neuroinflammation in Ischemic Stroke.Mol Neurobiol. 2024 Dec;61(12):10792-10804. doi: 10.1007/s12035-024-04225-1. Epub 2024 May 24. Mol Neurobiol. 2024. PMID: 38789893 Review.
-
A novel p55PIK signaling peptide inhibitor alleviates neuroinflammation via the STAT3/NF-kB signaling pathway in experimental stroke.J Stroke Cerebrovasc Dis. 2024 Jul;33(7):107736. doi: 10.1016/j.jstrokecerebrovasdis.2024.107736. Epub 2024 Apr 26. J Stroke Cerebrovasc Dis. 2024. PMID: 38679216
-
Role of Microglia in Stroke.Adv Neurobiol. 2024;37:405-422. doi: 10.1007/978-3-031-55529-9_23. Adv Neurobiol. 2024. PMID: 39207705 Review.
Cited by
-
Targeting microglia polarization with Chinese herb-derived natural compounds for neuroprotection in ischemic stroke.Front Cell Dev Biol. 2025 Jun 10;13:1580479. doi: 10.3389/fcell.2025.1580479. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40556734 Free PMC article. Review.
-
Exploring NMDAR pathways in ischemic stroke: implications for neurotoxic and neuroprotective mechanisms and therapeutic strategies.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 10. doi: 10.1007/s00210-025-04357-8. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40490524 Review.
References
-
- Feske SK (2021) Ischemic stroke. Am J Med 134:1457–1464 - PubMed
-
- GBD 2019 Stroke Collaborators (2021) Global, regional, and National burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol 20:795
-
- Tsao CW et al (2023) Heart disease and stroke statistics—2023 update: a report from the American heart association. Circulation 147:e93–e621 - PubMed
-
- Pluta R (2025) Neuroinflammation in the Post-Ischemic brain in the presence of amyloid and Tau protein. Discov Med 37(192):1–18 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical